Zenas BioPharma, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
ZBIO on Nasdaq
Location
1000 Winter St, Suite 1200, Waltham, MA

Insiders trading volume in the past year

Zenas BioPharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Enavate Sciences GP, LLC 10%+ Owner $63.9M +$15M +30.6% Sep 16, 2024
Fairmount Funds Management LLC Director $32.2M +$5.1M +18.8% Sep 12, 2024
Leon O. Moulder Jr Chief Executive Officer, Director $19.1M +$1.23M +6.87% Dec 3, 2024
Jason R. Nunn Director $18.9M +$15M +387% Sep 16, 2024
Sr One Capital Management, Llc 10%+ Owner $18.9M +$38M Sep 16, 2024
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $13.6M Sep 16, 2024
Patrick G. Enright Director $13.2M +$7.48M +132% Sep 12, 2024
Hongbo Lu Director $1M +$1M Sep 13, 2024
Ting Xiao Director Sep 12, 2024
Joseph L. Farmer President and Chief Operating Officer Sep 12, 2024
Orlando Oliveira Chief Commercial Officer Dec 16, 2024
Patricia L. Allen Director Sep 12, 2024
James P. Boylan Director Sep 12, 2024
Jennifer A. Fox Chief Business Officer and Chief Financial Officer Dec 16, 2024
John J. Orloff Director Sep 12, 2024

Recent Insider Transactions by Companies or Individuals for Zenas BioPharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.